Comparison of ezetimibe and atorvastatin versus atorvastatin alone on short-term major adverse cardiac events after percutaneous coronary intervention, a double-blind placebo-controlled randomized clinical trial

Authors

Institutions

Publication Details

Journal
Trials
Published
2025-03-28
DOI
https://doi.org/10.1186/s13063-025-08817-7
Citations
1
Primary Topic
Lipoproteins and Cardiovascular Health
Type
article
Field-Weighted Citation Impact
2.01

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Comparison of ezetimibe and atorvastatin versus atorvastatin alone on short-term major adverse cardiac events after percutaneous coronary intervention, a double-blind placebo-controlled randomized clinical trial

Seyed Alireza Sobhani, Farideh Dastsouz, Hossein Farshidi, Behzad Bijani et al.
1 citations
Trials
Lipoproteins and Cardiovascular Health
2.01
article

Comparison of ezetimibe and atorvastatin versus atorvastatin alone on short-term major adverse cardiac events after percutaneous coronary intervention, a double-blind placebo-controlled randomized clinical trial

Seyed Alireza Sobhani, Farideh Dastsouz, Hossein Farshidi, Behzad Bijani, Shahin Abbaszadeh
article en
1 citations

Abstract

No abstract available for this paper.
TrialsVol. 26(1)
Iran University of Medical Sciences (IR), Hormozgan University of Medical Sciences (IR), Shaheed Rajaei Cardiovascular Medical and Research Center (IR)
Hormozgan University of Medical Sciences
Good health and well-being
Openalex Percentile: Top 17%
Lipoproteins and Cardiovascular Health
2.01
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.